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Abstract
Despite advances in clinical imaging and grading our understanding of retinal immune responses and their morphological
correlates in experimental autoimmune uveoretinitis (EAU), has been hindered by the requirement for post-mortem
histology. To date, monitoring changes occurring during EAU disease progression and evaluating the effect of therapeutic
intervention in real time has not been possible. We wanted to establish whether optical coherence tomography (OCT) could
detect intraretinal changes during inflammation and to determine its utility as a tool for accurate scoring of EAU. EAU was
induced in C57BL/6J mice and animals evaluated after 15, 26, 36 and 60 days. At each time-point, contemporaneous
Spectralis-OCT scanning, topical endoscopic fundal imaging (TEFI), fundus fluorescein angiography (FFA) and CD45-
immunolabelled histology were performed. OCT features were further characterised on retinal flat-mounts using
immunohistochemistry and 3D reconstruction. Optic disc swelling and vitreous opacities detected by OCT corresponded to
CD45+ cell infiltration on histology. Vasculitis identified by FFA and OCT matched perivascular myeloid and T-cell infiltrates
and could be differentiated from unaffected vessels. Evolution of these changes could be followed over time in the same
eye. Retinal folds were visible and found to encapsulate mixed populations of activated myeloid cells, T-cells and microglia.
Using these features, an OCT-based EAU scoring system was developed, with significant correlation to validated histological
(Pearson r2 = 0.6392, P,0.0001, n = 31 eyes) and TEFI based scoring systems (r2 = 0.6784, P,0.0001). OCT distinguishes the
fundamental features of murine EAU in vivo, permits dynamic assessment of intraretinal changes and can be used to score
disease severity. As a result, it allows tissue synchronisation with subsequent cellular and functional assessment and greater
efficiency of animal usage. By relating OCT signals with immunohistochemistry in EAU, our findings offer the opportunity to
inform the interpretation of OCT changes in human uveitis.
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Introduction
As an animal model with features resembling those of human
intraocular autoimmune inflammatory disease, murine experi-
mental autoimmune uveoretinitis (EAU) has been central to many
of the advances and translational studies in ocular immunology
over the last decade [1,2]. Spontaneous and inducible EAU can be
obtained using a variety of wildtype and transgenic mouse strains
to achieve different disease kinetics, severity and polarity of
immune responses [3]. More recently, laboratories have advanced
our knowledge of EAU and thus human disease through assays
such as retinal multiparameter flow cytometric analysis. This has
facilitated the dissection of molecular mechanisms that determine
disease phenotype and the function, for example, of recruited
macrophages [4,5]. To date however, the inability to identify
histological changes in real time has limited our ability to correlate
cellular infiltrate and function with morphological changes.
Despite increasing sensitivity of flow cytometric analysis within
the retina, a robust readout of disease status would improve the
utility of EAU for preclinical translational studies. Currently,
morphological assessments are only possible with histology and
semi-quantitative scoring systems using either haematoxylin/eosin
[6] or CD45 (pan-leukocyte) immunolabelling [7]. Whilst histology
and flow cytometric assessment of cell infiltrate provide detailed
information at a single time-point, the terminal nature of these
analyses intrinsically precludes repeated scoring of the same
animal. This limitation is compounded by variation in EAU
development, amplitude and dynamics, with asymmetry even
between the eyes of the same animal [8]. To circumvent this, data
from large cohorts of mice are normally pooled, sacrificing
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information on individual variation and amalgamating results into
potentially misleading averages.
Progress towards overcoming these limitations culminated in the
introduction of topical endoscopic fundal imaging (TEFI) as a
scoring platform for murine EAU [9]. Using this technique,
repeated detailed images of the retina from the same eye could be
obtained over the entire timecourse of disease. By scoring these
fundus photographs for disc, vessel and structural changes, a
surrogate measure can be obtained, which has been shown
empirically to approximate to infiltration and histological scores
[10]. Thereby it has been possible to correlate disease changes
with cellular infiltration and confirm the effects of novel treatments
e.g. of drugs that affect cell trafficking [11,12].
Whilst a substantial advance, TEFI requires high levels of light
exposure and corneal instrumentation, that with cumulative use
may have the potential to cause damage to the retina and ocular
surface [13]. Disease can also be overestimated, predominantly by
failing to define normal optic disc appearance or in later stages
confusing perivascular scarring as active vasculitis. Furthermore
TEFI is unable to quantify vitreous infiltration or resolve
intraretinal changes and thus remains an inadequate surrogate
score for the gold standard of histology (using 2D colour images to
approximate 3D intraretinal tissue changes). For these reasons the
pursuit of improved systems has continued.
Optical coherence tomography (OCT) has revolutionised the
diagnosis, monitoring and treatment of human retinal and
macular disease and its application is now widespread in clinical
practice [14,15]. OCT discerns structure in the retina based on the
scatter of reflected light and can, dependent on laser wavelength,
reach axial resolutions down to 4 mm, advancing the prospect of
observing histological detail in vivo [16]. Over recent years
commercially available systems have been improved, adapted for
use in animals and now allow reliable imaging of features in the
rodent eye [17]. The most significant benefit of an OCT-based
EAU scoring system arises from the near-histological level of
detail, which would permit the same accurate staging of disease,
but repeated over time in the same eye. As a result, dynamic
intraretinal changes can be monitored and better defined in vivo.
In this study we aimed to refine our understanding of the
correlation between morphological changes and OCT features by
assessing the ability of OCT to detect retinal changes in C57BL/6J
mice undergoing EAU and devising a scoring system to parallel
histological scores. We found that OCT could distinguish between
diseased and control animals based on good correlation with
fundus fluorescein angiography (FFA), TEFI and histology.
Critical aspects of disease such as optic disc swelling, vasculitis
and structural damage were delineated with OCT and further
defined using immunohistochemistry and 3D reconstruction. We
were also able to define the nature of a so far ill understood OCT
feature, as an unusual retinal vascular malformation that arises
from day 36 in EAU. Finally it was possible to construct a scoring
system, which we confirmed correlated well with both histology
and TEFI based scores. Together this data provides evidence that
real time OCT monitoring and quantification of disease progres-
sion in murine EAU is feasible and can assist in defining the
functional-structural consequences of pathological immune re-
sponses in the retina.
Materials and Methods
Animals and Induction of EAU
Female C57BL/6J mice (Harlan, UK) at seven-weeks of age
were immunised for EAU and maintained with food and water ad
libitum in cages adjacent to complete Freund’s adjuvant (CFA)
controls. Mice with vascular abnormalities were genotyped by
sequencing and confirmed as rd8 (Crb1rd8/rd8) mutation free [18].
All procedures were performed under the UK Home office project
licence PPL 70/1279 and conformed to the Association of
Research in Vision and Ophthalmology (ARVO) statement for
the use of animals in ophthalmic and vision research.
For EAU induction, 500 mg per mouse of human RBP-31–20
peptide was injected subcutaneously, emulsified in CFA supple-
mented with 1.5 mg/mL M. tuberculosis H37RA (Difco laborato-
ries, BD, Oxford, UK). 1.5 mg of Pertussis toxin was simulta-
neously administered into the peritoneal space (Tocris Bioscience,
Bristol, UK). CFA control mice received the same regime,
including pertussis toxin and CFA, but substituting PBS for
RBP-3 peptide.
For all in vivo procedures, animals underwent anaesthesia with
injection of 200 ml medetomidine hydrochloride (1 mg/ml),
100 mg/ml ketamine (Orion pharmaceuticals, Helskinki, Finland),
and water in the ratio 5:3:42. Post-procedure anaesthesia was
reversed by injection of an equal volume of AntiSedan (Pfizer
pharmaceuticals, USA). Pupils were dilated for 5 minutes with
topical tropicamide 1% and phenylephrine 2.5% (Chauvin
Pharmaceuticals, Romford, UK).
Topical Endoscopic Fundus Imaging (TEFI)
Using a published method, a 5 cm endoscope 3 mm in outer
diameter (1218 AA; Karl Storz, Tuttlingen, Germany), was
connected by fibre-optic cable to a Nikon D300s digital camera
with a 12.3 megapixel charge-coupled device sensor and
Viscotears (Novartis Pharmaceuticals, UK) was used as a coupling
agent for corneal contact [10]. Contrast and brightness of the
fundus images were adjusted in Adobe Photoshop CS5.5 (Adobe
Systems Incorporatied, San Jose, USA). Using an adapted clinical
grading system, fundus images were scored in a masked fashion by
three assessors, according to changes in the optic disc, vessels and
surrounding retina [9].
Optical Coherence Tomographic (OCT) Imaging and
Fundus Fluorescein Angiography (FFA)
SpectralisTM HRA and OCT (Heidelberg Engineering, Heidel-
berg, Germany) with an aspheric, 80 mm focal length, near-infra-
red lens adaptor (Linos, Qioptiq, Luxembourg) was used to
capture images with a 30-degree angle of view. The OCT+IR
channel was used to correlate retinal position with the obtained
OCT optical section. Animals were injected in the peritoneal
space with 200 ml of 2% fluorescein in PBS. Simultaneous OCT
and fundus fluorescein angiography was obtained using the
autofluorescent channel of the SpectralisTM HRA. Viewing
module 5.7.0.9 and acquisition module 5.6.3.0 were used with
Heidelberg eye explorer version 1.7.1.0. Images were exported
and processed in Adobe Photoshop CS5.5 (Adobe Systems
Incorporated, San Jose, USA). Details of OCT-based EAU
scoring can be found in the results section and Figure S1.
Immunohistochemistry and Histology based EAU Scoring
For CD45 histological scoring, enucleated eyes were snap frozen
in optimal cutting temperature medium, serially sectioned at
15 mm and stained as previously published [10]. Briefly, following
acetone fixation and non-specific rabbit serum block, anti-CD45
antibody (AbD Serotec, Kidlington, UK) labelling underwent
chromogenic staining using a DAB substrate kit and haematoxylin
counterstain (Vector laboratories, Peterborough, UK). Scoring
was performed across the whole eye, selecting the most severe
example of disease present and marked according to a previously
OCT In Vivo Assessment and Scoring of Murine EAU
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described system capable of detecting subtle changes in infiltration
and structure [7].
Retinal flat-mounts were stained by adapting a published
protocol [18]. The cornea and lens are removed prior to four
relieving incisions and separation of retina from RPE along the
sub-retinal space. Following dissection, the retinae were placed
into 100% methanol overnight, then blocked and stained in 1%
BSA (Sigma Aldrich, UK), 3% Triton X-100 and 5% non-specific
goat serum (AbD serotec, UK). Antibodies were all used at 1:200
dilution including anti-collagen IV (code: 2150-1470, AbD serotec,
UK), an equal mix of anti-CD4 (code: 553043, BD Biosciences,
UK) and anti-CD8 (code: 553027, BD Biosciences, UK), anti-Iba1
(code: 019-19741, WAKO, Osaka, Japan) and biotinylated lectin
B4 from Bandeiraea simplicifolia (code: L2140, Sigma aldrich, UK)
[19]. Alexa fluor 488, 546 and 633 secondary antibodies
(Invitrogen-Molecular Probes, Leiden, The Netherlands) were
used at 1:500 dilution. Images were acquired by confocal laser
scanning microscopy (Leica DM5500Q, Leica Microsystems,
Germany). High-resolution z-stack images were used for 3D
reconstruction using Imaris software (Bitplane, Zurich, Switzer-
land).
Statistical Analysis
GraphPad Prism 5 for Windows was employed for statistical
analyses (GraphPad Software Inc, La Jolla, USA). A P-value below
0.05 was considered statistically significant.
Results
OCT Detects Key Tissue Changes Associated with EAU in
C57BL/6 Mice
To determine if EAU-induced changes could be detected by
OCT in C57BL/6 mice and used to score disease status, three
independent cohorts totalling 33 mice (12, 12 and 9 respectively)
were induced at two-week intervals. Assessment was performed at
days 15, 26, 36 and 60 post-induction. CFA control animals,
which received only complete Freund’s adjuvant and pertussis
toxin, were followed through to day 60. At each time-point all
animals underwent TEFI and OCT scanning, with simultaneous
fundus fluorescein angiography (FFA) in a subset. Animals were
selected randomly at each imaging session for histological or
retinal flat-mount analysis (n = 5–7 eyes per group). Other cohorts
were observed up to 80 days post-induction. We commenced our
study by looking at features critical to histological EAU assessment
and wished to determine whether it was possible to detect the same
changes by OCT. See Figure S2 for a description of OCT
correlation to retinal anatomy.
Optic Disc Changes
Initial changes in EAU are evident at the optic disc and
observed clinically by TEFI as optic nerve swelling with loss of
margin definition. An example is shown in Figure 1A. In the
same representative animal, confirmation of disease activity is
demonstrated by FFA as leakage of dye (Figure 1B) when
compared with the matched CFA control. In EAU, hyperfluor-
escence at the optic disc and vascular enlargement occur as a result
of inflammatory infiltrate and vascular barrier breakdown. Using
OCT scanning, a section through the horizontal centre of the disc
can be obtained which reflects underlying changes of infiltration
and oedema (Figure 1C). CD45+ immunohistological labelling
from the same eye confirms the presence of immune cells
infiltrating the disc (Figure 1D), which are absent in the control
(Figure 1H). Furthermore, any oedema observed by OCT
imaging (Figures 1B & 1C) is largely lost during tissue processing
and cells infiltrating the vitreous are frequently displaced in
sectioning. Most importantly, although TEFI in the CFA control
animal demonstrates a clinically diseased optic nerve (Figure 1E),
with FFA, OCT and histology there is no evidence of inflamma-
tion. In contrast during EAU, vitreous opacities around the disc
are visible on OCT. Both vitreous activity and disc swelling appear
to reach a peak between days 26 to 36 post-induction and decrease
by day 60 (Figure S3). The data shows that OCT delineates, with
greater sensitivity and specificity than TEFI, both optic disc and
vitreous cavity inflammatory changes throughout EAU; two
components central to the assessment of disease status.
Structural Changes
To assess the ability of OCT to detect intraretinal structural
changes, we examined morphological alterations in eyes with
widespread, discrete, chorioretinal lesions - a hallmark of disease,
which increases in later stages (Figure 2A, white arrows). OCT
scans of these lesions revealed dome-shaped signals at the level
corresponding to the subretinal space, which displace the
photoreceptor and outer nuclear layer upwards into the inner
nuclear layer (Figure 2B, C). In many instances, the largest
lesions occur in proximity to heavily infiltrated vessels and a
representative example is shown with histology (Figure 2D). This
additionally identifies these lesions as the ‘retinal folds’ frequently
observed in histological sections and adopted into the structural
assessment of several EAU scoring systems [6,7]. As these folds are
poorly characterised we stained retinal flat-mounts for T-cells,
microglia and myeloid cells to assess their spatial relationship
(Figure 2E). The representative example underwent 3D recon-
struction, which illustrates domed cavities projecting into the outer
nuclear layer, with a mixed population of cells contained within
most likely extending from the subretinal space (Figure 2F).
Lectin B4, which labels a subset of the myeloid lineage as well as
vascular endothelium [20] was used to stain this structure. As no
vessels were observed in the regions of the folds, or when stained
with collagen IV (data not shown), lectin B4 expression represents
activated myeloid cells [19] and 3D reconstruction further
emphasises the encapsulation of inflammatory cells (myeloid and
T-cells) in the fold and within the subretinal space (seeMovie S1).
Vascular Changes
Vasculitis or perivascular immune infiltrate is a predominant
feature in murine EAU [1]. To assess vascular changes in vivo and
ex vivo, we compared TEFI, FFA and OCT images of CFA control
(Figure 3A–C) and EAU (Figure 3D–G, I) animals with
corresponding immunohistochemistry for vascular and inflamma-
tory cell markers on retinal flat-mounts (Figure 3H & 3J).
In CFA control mice, vessels assessed by TEFI (Figure 3A),
FFA (Figure 3B) and OCT (Figure 3C), revealed a normal, non-
inflamed appearance. In contrast in EAU, TEFI (Figure 3D)
detects several abnormal, inflamed vessels that were also identified
on corresponding infrared SLO (Figure 3E) and FFA (Figure 3F)
images as well as on matched OCT scans (Figure 3G & 3I).
Two large superficial retinal vessels were observed on the OCT
scan (Figure 3G) and their corresponding appearance assessed on
flat-mount (Figure 3H). Interestingly, the abnormal vascular
signal, enlargement and distortion of surrounding retinal tissue on
OCT correlated to a dense perivascular infiltrate that surrounded
the vessel (Figure 3G, upward pointing arrowhead) while the
vessel lacking substantial perivascular accumulation of cells was
small, dense and with preserved adjacent layers on OCT.
(Figure 3G, downward pointing arrowhead).
In several mice, including wildtype, retinal vessels were
occasionally observed below the inner nuclear layer. Inflammation
OCT In Vivo Assessment and Scoring of Murine EAU
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of these vessels resulted in a dramatically different appearance on
OCT (Figure 3I), with attenuation of signal in almost the full
thickness of the retinal tissue and was often associated with
evidence of fluorescein leakage in FFA (Figure 3F). Whilst it is not
possible to detect oedema on retinal flat-mounts, myeloid and T-
cells were found to be closely associated with these inflamed vessels
(Figure 3J). Given that such changes can be detected on OCT,
the origin and evolution of vasculitis, with its effects upon
surrounding tissues might be further delineated in vivo using this
technique.
Figure 1. EAU in the C57BL/6J mouse induces optic nerve head changes detectable on OCT. Representative images from an eye 15 days
post-induction of EAU (A–D) and matched CFA control (E–H) using four modalities. Blurred optic disc margins on TEFI (A) and disc hyperfluorescence
on FFA (B) are seen in EAU. Green arrows show the location and orientation of the OCT scan. Red dots indicate where the discrete signal from the
outer plexiform layer becomes obscured by disc enlargement, as a landmark to compare between eyes. Note a wider separation and vitreous
opacities in EAU (C). Matched histology demonstrates CD45+ infiltration (DAB in brown with haematoxylin counterstain) during EAU (D). With TEFI
alone (E), it is possible that changes in disc appearance would erroneously be identified as disease with infiltration in the CFA control, as OCT and
immunohistochemistry do not corroborate any evidence of disease.
doi:10.1371/journal.pone.0063002.g001
Figure 2. Abnormal OCT signals in vivo correspond to structural changes and associated cellular infiltrates. Images from an eye
80 days post-induction of EAU (A–C) can be interpreted using matched ex vivo histology (D–F). On TEFI (A) multiple pale retinal lesions (white
arrowheads) are present. The infrared (IR) image (B) marks the position and orientation of the simultaneously obtained OCT scan (C). Focal changes at
the level of the subretinal space/deep retina correspond to the observed lesions (red arrowheads). (D) Note the CD45+ cellular infiltrate (DAB in
brown with haematoxylin counterstain) around the superficial vessel and under the displaced outer nuclear layer. A limited projection image (E) and
3D reconstruction (F) of the stained retinal flat-mount identifies these lesions as folds in the outer nuclear layer containing T cell - CD4+ & CD8+ (red),
myeloid - lectin B4 binding (white) and Iba1+ (green) cell populations protruding from the subretinal space (DAPI in blue). Movie S1 shows an
animated version of this panel.
doi:10.1371/journal.pone.0063002.g002
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Detection of Novel Vascular Changes using OCT
Having established that key features known to occur in EAU
can be identified, OCT was employed to describe vascular
structures not classically recognised as part of the inflammatory
process. During combined FFA and OCT imaging of mice from
day 36 post-induction, an atypical pattern was detected and one
representative example is presented (Figure 4A). The corre-
sponding retinal flat-mount confirmed the lesion as vascular in
origin and associated with both myeloid and T-cell infiltrates
(Figure 4B–C). Detailed analysis of the tissue where separated
from the RPE, revealed patches of pigment on brightfield
microscopy, likely to reflect an area of abnormal retinal interaction
with adjacent RPE (Figure 4E). Collagen IV labelled vessels
appear to pass through this area as indicated. 3D reconstruction
highlights vascular penetration through the outer nuclear layer
and connection to the superficial retinal circulation on both sides
of the plexus (Figure 4F). For a detailed view of the entire region,
seeMovie S2. The matched OCT scan shows an expansion of the
layer corresponding to the RPE and an overall appearance that
discriminates it from the early changes of vasculitis (Figure 4G).
Using the reconstruction, it is possible to appreciate both how the
OCT signal might be obtained and the association of activated
myeloid cells (lectin B4 binding) with the vessels (Col IV,
Figure 4H). Whether this lesion represents choroidal neovascu-
larisation or intraretinal telangiectasia is uncertain, but it can be
distinguished from typical vasculitis even with OCT alone.
Derivation, Application and Calibration of the OCT
Scoring System
Having ascertained that it is possible to detect core features
during the development and course of EAU, we proceeded to
design an OCT-based scoring system. Our focus was on end-user
simplicity, speed and eliminating subjectivity. Scoring series
acquisition for each eye involves eight OCT scans positioned
around the posterior pole. Full details are described in Figure S1.
Once established, the average imaging time was six minutes per
eye.
Four features composed the scoring system, which were aligned
to provide maximal correlation with histology and include a count
of OCT signals in the vitreous (vitreous cellular infiltration), disc
enlargement (oedema and cell infiltration), abnormal vasculature
associated signals (vasculitis and perivascular infiltrate) and
intraretinal (morphological) changes (Table 1). Vascular change,
as a central feature of EAU was weighted accordingly. Vitreous
opacities correlate to aggregates of infiltrating cells and can be
counted objectively. The assessment of disc enlargement is a
challenge, as on-machine measurement is strongly affected by
many factors including hardware setup, focal plane and scan
placement. The final measurement is an average of horizontal and
vertical disc scans. In order to minimise false positive results, initial
calibration against a test CFA control group is required
(standardisation using the same protocol and OCT machine
within each laboratory is necessary). All subsequent disc measure-
ments are then determined as a ratio of the averaged CFA
controls, which is squared and multiplied by a fixed weighting
factor to combine with other scores (Table 1). Vascular change is
expressed as a ratio of total scanned vessels against those
demonstrating abnormal OCT signals. For intraretinal structural
changes the peripheral scans are divided into ten equal segments
and scored based on the number of segments with any
abnormality. A worked example is provided in Figure S4.
Scoring System Validation
Whilst in humans, repeated Spectralis OCT scans can be locked
to an identical location, as a result of optical constraints this
process proves difficult in the mouse. Nevertheless, features can be
manually followed in a single eye and to demonstrate the potential
of OCT, examples are presented in Figure S3. Quantitative
analysis is possible by combining data from all three cohorts to
show the time-course of EAU scores generated using our OCT
system, TEFI and CD45 immunolabelled histology (Figure 5A–
C). Scoring was performed by three masked assessors and the
averaged results are displayed. The data from each system are
presented in raw form and not normalised to one scheme. All three
modalities reflect the expected course of EAU and correlate
significantly with each other (Figure 5D–F). OCT scores
correlated well with histology (Pearson r2 = 0.6392, P,0.0001,
n = 31 eyes), affirming the hypothesis that inflammatory changes
in the limited 30-degree field of OCT are directly proportional to
whole eye changes sampled by histology. OCT and TEFI correlate
(r2 = 0.6784, P,0.0001), with TEFI also related to histology
(r2 = 0.5525, P,0.0001).
Discussion
In this study we have provided evidence that OCT imaging is a
viable method for evaluating murine EAU and quantifying disease
in vivo. We also present an OCT-based scoring system, which
correlates well with existing TEFI and histology based analyses.
OCT thus provides a tool for following dynamic intraretinal
changes and will permit the reconciliation of mounting functional
and cellular data from the EAU model.
OCT Correlates with Current EAU Scoring Methods and
has Distinct Advantages
In C57BL/6 mice, for the range of pathology historically used to
stage EAU severity – vitreous, disc, vessel and retinal structural
changes – discrimination was possible. OCT can therefore be
added to the range of techniques used for disease assessment, and
will facilitate where appropriate, substitution for post-mortem
histology and reduction and refinement of animal usage. Histology
will inevitably still be performed for first describing novel findings
and for corroborative immunophenotyping, but can otherwise be
widely replaced by OCT, as it remains conceptually analogous
and directly correlated to post-mortem histology scores. The
overall time required for imaging and scoring is also markedly less
Figure 3. OCT identifies vascular changes in EAU and appearances are altered by depth and degree of infiltration. This CFA control
eye has normal TEFI (A) and FFA (B) appearances. The green arrow indicates the orientation and position of the OCT scan (C), which transects a
superficial retinal arteriole (red arrowhead) and vein (blue arrowhead). Matched images from an eye at day 36 post-induction of EAU demonstrate the
range of changes (D–J). Corresponding disc swelling and vascular changes are seen on TEFI (D) and infrared SLO (E), with mild leakage on FFA (F).
Green arrows indicate the location and orientation of OCT scans. One scan transects two large vessels travelling near the retinal surface (G). The
vessel (collagen IV in red) with altered OCT signal in the perivascular tissue (upward pointing arrowheads) is densely infiltrated with myeloid - lectin B4
binding (white) and T cell - CD4+ & CD8+ (green) cells as shown by immunohistochemistry on retinal flat mount (H). This is in contrast to the other
vessel (downward pointing arrowheads), which lacks any localised infiltrate. Diffuse hyper-reflective signal on OCT (I) corresponds to a deep retinal
vein, with associated cellular infiltrate (J). The blue line indicates alignment with the OCT scan.
doi:10.1371/journal.pone.0063002.g003
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per eye once processing, sectioning and staining for histology are
accounted for.
A further advantage is that OCT can be used to directly observe
features in vivo such as oedema or vascular leakage, which are not
easily detectible on histology due to tissue processing. Further-
more, this platform has the ability to simultaneously perform FFA
and scan at the exact location of any lesion. However, we noted
that OCT alone was able to distinguish specific features in tissue
surrounding vessels as a surrogate for leakage.
OCT delivers a closer substitute for histology than TEFI. Whilst
current in vivo monitoring with TEFI can detect disc and vessel
alterations, it cannot detect intraretinal or vitreous changes [10].
OCT avoids the disadvantages of intense light exposure, corneal
contact and appears not to overestimate disc involvement to the
same degree. Nevertheless, TEFI still has a role as a useful and
quick screening step, identifying animals for subsequent detailed
OCT scoring or other assessments.
Inter- and intra-animal variation in EAU models often result in
a large spread and require many animals to obtain reproducible
data from functional or cellular analysis. This data shows that
OCT will allow intraretinal synchronisation of disease stage within
experimental groups prior to sacrifice of animals, which conse-
quently will improve outcome measures. By scoring disease
without post-mortem histology, animals can be repurposed to
other analyses (flow cytometry, Q-PCR, cytokine ELISA) with
additional knowledge of the exact disease stage of each eye. Using
Figure 4. OCT imaging can guide identification and characterisation of novel features within the EAU model. Fundus fluorescein
angiography (FFA) on an eye 36 days post-induction of EAU revealed an abnormality initially thought to lie within the pre-defined spectrum of
vasculitis (A). Retinal flat-mount revealed an atypical vascular lesion arising along the course of a large vessel (B). 3D reconstruction of the region
enclosed by the white box, with CD4+ & CD8+ cells (green) displayed (C). Magnified view of the FFA (D) correlates with a combined collagen IV (red)
and brightfield projection image viewed from the subretinal space towards the vitreous (E). Note the black patch corresponding to RPE adherence
during retinal separation. Vessels pass through this region (example indicated by white arrowhead) having arisen from the retina after penetrating
the outer nuclear layer (nuclei in blue) - highlighted in the reconstruction (F). OCT demonstrates a unique, dense signal appearance (G), inconsistent
with more widely observed vasculitic changes in EAU. The arrangement seen on sagittal reconstruction (H) might partly explain the appearance,
which could be consistent with inflammatory induced intraretinal telangiectasia, vascular reorganisation or neovascular buds. Lectin B4 staining is
displayed (white). The green arrow indicates the location and orientation of the OCT scan. See Movie S2 for an animated 3D reconstruction.
doi:10.1371/journal.pone.0063002.g004
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OCT can also reduce overall animal numbers needed, consistent
with universal targets for the replacement, reduction and
refinement (3R’s) of animal use [21].
OCT can Guide the Discovery and Characterisation of
Novel Features
We have demonstrated that by employing OCT we can not
only evaluate vitreous and intraretinal changes in more detail, but
also identify and assess in a more targeted way, novel features of
Table 1. Range and calculation of final OCT based EAU scores.
Sub-scoring
category Description
Raw score range
per eye
Alteration
factor
Maximum final EAU
score
Vitreous involvement Absolute count of discrete opacities in the vitreous
space up to a maximum of 150. The count from the
worst affected scan is used.
0–150 None 0–150
Disc enlargement On-machine measure of the linear distance between the
termination of the outer plexiform layer equivalent on
either side of the disc (See Figure 1). For each eye,
average the results of the horizontal and vertical
disc scans.
Relative value to
control CFA group
(Measure/average CFA control
group measurement)2 then
multiplied by 35
25.6–92.0
(CFA control group average
of 1695 units in this cohort)
Vascular involvement Number of abnormal vessels as a ratio of total vessels
scanned based on OCT appearance. Two disc
centred scans excluded.
0–1 Multiply by 300 0–300
Structural change Using six scans (non-disc centred) only, each is divided
into 10 equal vertical segments. The total number with
any abnormality present is counted.
0–60 Multiply by 1.5 0–90
25.6–632
Weighting was determined by correlation to histology, of which vascular change was most parallel. On average most scores will lie between 20 and 600 points. The
range for the cohort in our experiments is presented.
doi:10.1371/journal.pone.0063002.t001
Figure 5. OCT-based EAU severity scoring correlates well with established measures and routine use should be considered. Absolute
scores for the combined cohort at each time-point from day 15 to day 60 post-induction of EAU for OCT (A), histology (B) and TEFI (C). Each point
shows the average of scores from three, masked, trained assessors. n = 31 eyes, treated independently by one-way ANOVA (P,0.0002 for each), with
Tukey post hoc test for multiple comparison (* = P,0.05, ** = P,0.01, *** = P,0.001). SD are shown. Pearson correlations and linear regression of the
values are displayed for comparisons between OCT and histological (D), TEFI and OCT (E) and TEFI and histological scores (F). Correlations are
significant and correlate well between each other.
doi:10.1371/journal.pone.0063002.g005
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the inflamed retina. Using our platform, vessels can be imaged
with combined FFA and OCT to localise leakage and analyse
surrounding tissue in the associated areas. Deep retinal folds can
be imaged and importantly, distinguished on OCT from other
changes such as the abnormal vascular telangiectasia we identified.
This feature in EAU was identified from day 36 onwards showing
vascular remodelling to occur earlier in disease course than
indicated by similar vascular membranes recently observed only
from day 60 post-induction [22]. The vascular lesions share some
similarities with those described in degenerative models with a
chronic low grade inflammatory component, such as rhodopsin
kinase knockout mice [23] or those carrying the rd8 mutation [18].
The mice used in our study carry neither defect and thus the lesion
may represent a more widespread feature of tissue remodelling in
response to degenerative or inflammatory processes in the retina.
Our data illustrates such changes, with vessels extending through
the outer nuclear layer and under the RPE, before reconnecting
with the superficial retinal vasculature. The vessels are unlikely to
represent choroidal neovascularisation as neither FFA findings nor
the irregular, yet ordered splay of the abnormal vessels are
characteristic of this. Further analysis including 3D scanning
electron microscopy to prove the integrity of Bruch’s membrane
would be required to confirm this assertion.
OCT Scoring and Future Directions
Construction of the OCT scoring system proved complex and
retaining adequate capture of detail had to be balanced against
user simplicity. Our system has been designed purposely to remove
subjectivity where possible and unlike histological and TEFI
scoring systems does not use imprecise stratification such as ‘mild,
moderate or subtotal’. The structural sub-score, calibrated for
broad overview and time efficiency does not distinguish between
subtypes of retinal changes. As such it remains necessary to
carefully study specific structural features as required for the
precise purpose of each experiment.
As EAU in rats and B10.RIII mice is more severe [24,25], the
current data is based on C57BL/6 mice since it permits detailed
imaging of the retina at critical stages. The largest constraint is the
limitation of the degree of optical resolution. Further refinements
in both the hardware and optics for rodent imaging will
inevitability increase the quality of data obtained, which will
allow progressively improved scoring accuracy and characterisa-
tion. Detailed analysis of choroidal changes may be possible using
long wavelength OCT, whilst employing emerging adaptive optics
technology may eventually allow the observation of dynamic
processes on a single cell level in vivo [26]. More work to precisely
delineate temporal changes and responses to therapeutic inter-
vention with OCT are the likely next steps to be taken.
Interpreting OCT Changes in Human Intraocular
Inflammatory Disease by Histopathological Correlation
with Murine EAU
Several of the features we have described in EAU reflect OCT
changes seen in some human posterior segment inflammatory
diseases [27,28]. An additional major benefit of using our
approach lies in the ability to directly correlate scan features with
matched tissue, which can be directly analysed to identify immune
cell composition and altered function. Due to the paucity of
human material for histology, an identical human study has not
been feasible. OCT is however, already being used in clinical
practice to phenotype and monitor posterior uveitis [29]. By
further examining other preclinical animal models, including
humanised and spontaneous EAU in mice, more accurate
correlations might be drawn [1]. Conversely, screening new
EAU models with OCT for retinal changes closest to those of
human disease, will allow selection and refinement during
development. In the clinic, it remains challenging to judge
remission of posterior segment inflammatory disease or detection
of early recurrence and relapse. Quantification and analysis of
OCT features other than macular oedema, as we have used here
in EAU, could distinguish remission versus low-grade chronic
inflammation as well as tissue remodelling in order to guide
clinical decision-making.
Supporting Information
Figure S1 OCT based EAU scoring scan acquisition. A
summary of the imaging series for scoring, using an example
composition. For each eye, eight combined IR+OCT scans are
acquired (A–H). Simultaneous FFA can be performed where
required. The 30-degree field of view is centred on the optic nerve
head. A)Horizontal scan through the disc. B) Horizontal scan, 30-
degrees superior to the disc. C) Horizontal scan, 30-degrees
inferior to the disc. D) Horizontal scan, 60-degrees superior to the
disc. E) Vertical scan through the disc. F) Vertical scan, 30-
degrees temporal to the disc. G) Vertical scan, 30-degrees nasal to
the disc. H) Horizontal scan, 60-degrees inferior to the disc. See
Figure S4 for worked scoring of the same image set.
(TIF)
Figure S2 The appearance and correlation with retinal
anatomy obtained by OCT scanning. An OCT scan from a
non-induced C57BL/6 mouse is displayed next to a matched
histological section stained with haematoxylin and eosin.
(TIF)
Figure S3 OCT can track the development of tissue
changes over time. Each column illustrates the development of
a feature from the identical eye of an animal at the same manually
located region on OCT for the four main features. Due to the
intrinsic variability of the model, the timing and severity of
changes varies between animals, but a general trend to early
inflammation and late reduction in disease is evident. Note that it
is impossible to directly quantify the degree of vitreous or
intraretinal involvement using TEFI alone.
(TIF)
Figure S4 A worked example of the scoring system
using the image acquisition described in Figure S1. Using
all eight scans, each eye is scored across four domains and the raw
results displayed. The number of discrete vitreous opacities,
separated from the retina are counted in the scan that shows the
strongest effect (A). Clusters that would receive scores are
illustrated in the red box. A vertical and horizontal average of
disc swelling is measured using on-machine software between the
terminations of the layer corresponding to the outer plexiform
layer (B). Across the six non-disc scans, the proportion of all
abnormal vessels out of the total transected by all scans is
calculated (C). The infrared scan can guide vessel location on the
OCT (green arrow indicates position of the scan). Non-disc scans
are then divided into ten equal vertical segments and the
proportion containing any abnormality (including inflamed vessels,
excluding vitreous changes) are counted (D). CFA control animal
reference scans should be compared. We have not included
discrete hyper-reflective changes along the outer plexiform layer or
nerve fibre layer, as these are likely to reflect small vessels and
appear in controls.
(TIF)
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Movie S1 3D reconstruction of retinal folds in an eye 80
days post-induction of EAU.
(AVI)
Movie S2 3D reconstruction of an intraretinal vascular
abnormality in an eye 36 days post-induction of EAU.
(AVI)
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